Search
Advertisement
Stock to buy: Airtel, Dr Reddys, Motilal Oswal among top picks — targets, stop loss & more

Stock to buy: Airtel, Dr Reddys, Motilal Oswal among top picks — targets, stop loss & more

An analyst from Master Capital Services said that Bharti Airtel is witnessing a bullish reversal after breaking out of an ascending triangle pattern, indicating a shift in trend.

Pawan Kumar Nahar
Pawan Kumar Nahar
  • Updated May 4, 2026 9:07 AM IST
Stock to buy: Airtel, Dr Reddys, Motilal Oswal among top picks — targets, stop loss & moreMotilal Oswal is showing a constructive turnaround after forming a double bottom, marking a shift in trend from bearish to bullish, said the analyst.

Amid the rising volatility in the Indian stock markets, led by feeble geopolitical and domestic cues, Vishnu Kant Upadhyay, AVP of Research at Master Capital Services has suggested three stocks to buy, based on the technical charts including Dr Reddys Laboratories Ltd, Bharti Airtel and Motilal Oswal Financial Services Ltd. Here's what he said on these stocks:
 

Advertisement

Related Articles

Motilal Oswal Financial Services | Buy | Target Price: Rs 880-900 | Stop Loss: Rs 730

Motilal Oswal is showing a constructive turnaround after forming a double bottom, marking a shift in trend from bearish to bullish. The stock has since reclaimed both short and long term moving averages, indicating improving momentum and strong trend alignment. On a broader timeframe, price action is shaping an inverse head and shoulders pattern, reinforcing the positive outlook. Sustained strength above current levels could lead to further upside, with the overall structure favouring continuation of the emerging uptrend.
 

Bharti Airtel | Buy | Target Price: Rs 2,000-2,040 | Stop Loss: Rs 1,800

Bharti Airtel Ltd is witnessing a bullish reversal after breaking out of an ascending triangle pattern near the Rs 1,890 zone, indicating a shift in trend. Earlier, a positive RSI divergence around Rs 1,750 signalled fading downside momentum, which has now translated into a recovery in price action. The stock has also moved back above its short term moving averages, reflecting improving structure and strengthening momentum. As long as it sustains above the breakout level, the setup remains constructive, with potential for a gradual extension of the ongoing upward move.
 

Advertisement

Dr Reddys Laboratories  | Buy | Target Price: Rs 1,425-1,460 | Stop Loss: Rs 1,250

Dr Reddys is witnessing a constructive pullback towards its earlier breakout zone around Rs 1,320, suggesting a healthy retracement within an ongoing uptrend. The breakout was supported by strong volume expansion, reinforcing bullish conviction. The stock continues to trade above its key moving averages, indicating positive alignment and sustained strength. Price action hints at accumulation on dips, and as long as it holds above the support zone, with RSI at 59, it appears well positioned to continue its ongoing positive trend.

Disclaimer: Business Today provides stock market news for informational purposes only and should not be construed as investment advice. Readers are encouraged to consult with a qualified financial advisor before making any investment decisions.
Published on: May 4, 2026 9:07 AM IST
    Post a comment0